Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms

Tara M. Connelly, Arthur S. Berg, Leonard R. Harris, David L. Brinton, John P. Hegarty, Sue M. Deiling, David B. Stewart, Walter A. Koltun

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background Neoplasia complicating ulcerative colitis (UC-neoplasia) is a problem that is poorly addressed by present surveillance techniques. The association of greater than 300 single nucleotide polymorphisms (SNPs) with inflammatory bowel disease (IBD) suggests the possibility that certain genetic polymorphisms might identify patients with UC destined for malignant degeneration. This present study tested the hypothesis that presently known IBD-associated SNPs may correlate with UC-neoplasia. Materials and methods A total of 41 patients with UC-neoplasia (mean age 56 ± 2.1 years) were identified from our divisional IBD Biobank (low-grade dysplasia n = 13, high-grade dysplasia n = 8, colorectal cancer [CRC] n = 20). These patients were individually age, sex, and disease duration matched with UC patients without neoplasia. Primary sclerosing cholangitis and family history of CRC were recorded. Patients were genotyped for 314 of the most commonly IBD-associated SNPs by a custom SNP microarray. Logistic regression and Fischer exact test were used for statistical analysis. Results After Bonferroni correction, none of the 314 IBD-associated SNPs correlated with UC-neoplasia when compared with matched UC controls. The incidence of primary sclerosing cholangitis was greater in the UC-neoplasia group (10/41, 24% vs 3/41, 7%; P =.03) compared with UC controls. The severity of neoplasia (low grade dysplasia versus high grade dysplasia versus CRC) correlated with disease duration (7.9 vs 13.4 vs 20.7 years, respectively). Conclusion The lack of correlation between well-known IBD-associated SNPs and UC-neoplasia demonstrated in this study suggests that the development of neoplasia in patients with UC is associated with genetic determinants other than those that predispose to inflammation or results from posttranslational modifications or epigenetic factors rather than germline polymorphisms.

Original languageEnglish (US)
Pages (from-to)253-262
Number of pages10
JournalSurgery (United States)
Volume156
Issue number2
DOIs
StatePublished - Aug 2014

Fingerprint

Ulcerative Colitis
Inflammatory Bowel Diseases
Single Nucleotide Polymorphism
Neoplasms
Colorectal Neoplasms
Sclerosing Cholangitis
Genetic Polymorphisms
Post Translational Protein Processing
Epigenomics
Logistic Models
Inflammation
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Connelly, Tara M. ; Berg, Arthur S. ; Harris, Leonard R. ; Brinton, David L. ; Hegarty, John P. ; Deiling, Sue M. ; Stewart, David B. ; Koltun, Walter A. / Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms. In: Surgery (United States). 2014 ; Vol. 156, No. 2. pp. 253-262.
@article{4c7e1dc718be480db3ce2d3cba8b95b0,
title = "Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms",
abstract = "Background Neoplasia complicating ulcerative colitis (UC-neoplasia) is a problem that is poorly addressed by present surveillance techniques. The association of greater than 300 single nucleotide polymorphisms (SNPs) with inflammatory bowel disease (IBD) suggests the possibility that certain genetic polymorphisms might identify patients with UC destined for malignant degeneration. This present study tested the hypothesis that presently known IBD-associated SNPs may correlate with UC-neoplasia. Materials and methods A total of 41 patients with UC-neoplasia (mean age 56 ± 2.1 years) were identified from our divisional IBD Biobank (low-grade dysplasia n = 13, high-grade dysplasia n = 8, colorectal cancer [CRC] n = 20). These patients were individually age, sex, and disease duration matched with UC patients without neoplasia. Primary sclerosing cholangitis and family history of CRC were recorded. Patients were genotyped for 314 of the most commonly IBD-associated SNPs by a custom SNP microarray. Logistic regression and Fischer exact test were used for statistical analysis. Results After Bonferroni correction, none of the 314 IBD-associated SNPs correlated with UC-neoplasia when compared with matched UC controls. The incidence of primary sclerosing cholangitis was greater in the UC-neoplasia group (10/41, 24{\%} vs 3/41, 7{\%}; P =.03) compared with UC controls. The severity of neoplasia (low grade dysplasia versus high grade dysplasia versus CRC) correlated with disease duration (7.9 vs 13.4 vs 20.7 years, respectively). Conclusion The lack of correlation between well-known IBD-associated SNPs and UC-neoplasia demonstrated in this study suggests that the development of neoplasia in patients with UC is associated with genetic determinants other than those that predispose to inflammation or results from posttranslational modifications or epigenetic factors rather than germline polymorphisms.",
author = "Connelly, {Tara M.} and Berg, {Arthur S.} and Harris, {Leonard R.} and Brinton, {David L.} and Hegarty, {John P.} and Deiling, {Sue M.} and Stewart, {David B.} and Koltun, {Walter A.}",
year = "2014",
month = "8",
doi = "10.1016/j.surg.2014.03.017",
language = "English (US)",
volume = "156",
pages = "253--262",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms. / Connelly, Tara M.; Berg, Arthur S.; Harris, Leonard R.; Brinton, David L.; Hegarty, John P.; Deiling, Sue M.; Stewart, David B.; Koltun, Walter A.

In: Surgery (United States), Vol. 156, No. 2, 08.2014, p. 253-262.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms

AU - Connelly, Tara M.

AU - Berg, Arthur S.

AU - Harris, Leonard R.

AU - Brinton, David L.

AU - Hegarty, John P.

AU - Deiling, Sue M.

AU - Stewart, David B.

AU - Koltun, Walter A.

PY - 2014/8

Y1 - 2014/8

N2 - Background Neoplasia complicating ulcerative colitis (UC-neoplasia) is a problem that is poorly addressed by present surveillance techniques. The association of greater than 300 single nucleotide polymorphisms (SNPs) with inflammatory bowel disease (IBD) suggests the possibility that certain genetic polymorphisms might identify patients with UC destined for malignant degeneration. This present study tested the hypothesis that presently known IBD-associated SNPs may correlate with UC-neoplasia. Materials and methods A total of 41 patients with UC-neoplasia (mean age 56 ± 2.1 years) were identified from our divisional IBD Biobank (low-grade dysplasia n = 13, high-grade dysplasia n = 8, colorectal cancer [CRC] n = 20). These patients were individually age, sex, and disease duration matched with UC patients without neoplasia. Primary sclerosing cholangitis and family history of CRC were recorded. Patients were genotyped for 314 of the most commonly IBD-associated SNPs by a custom SNP microarray. Logistic regression and Fischer exact test were used for statistical analysis. Results After Bonferroni correction, none of the 314 IBD-associated SNPs correlated with UC-neoplasia when compared with matched UC controls. The incidence of primary sclerosing cholangitis was greater in the UC-neoplasia group (10/41, 24% vs 3/41, 7%; P =.03) compared with UC controls. The severity of neoplasia (low grade dysplasia versus high grade dysplasia versus CRC) correlated with disease duration (7.9 vs 13.4 vs 20.7 years, respectively). Conclusion The lack of correlation between well-known IBD-associated SNPs and UC-neoplasia demonstrated in this study suggests that the development of neoplasia in patients with UC is associated with genetic determinants other than those that predispose to inflammation or results from posttranslational modifications or epigenetic factors rather than germline polymorphisms.

AB - Background Neoplasia complicating ulcerative colitis (UC-neoplasia) is a problem that is poorly addressed by present surveillance techniques. The association of greater than 300 single nucleotide polymorphisms (SNPs) with inflammatory bowel disease (IBD) suggests the possibility that certain genetic polymorphisms might identify patients with UC destined for malignant degeneration. This present study tested the hypothesis that presently known IBD-associated SNPs may correlate with UC-neoplasia. Materials and methods A total of 41 patients with UC-neoplasia (mean age 56 ± 2.1 years) were identified from our divisional IBD Biobank (low-grade dysplasia n = 13, high-grade dysplasia n = 8, colorectal cancer [CRC] n = 20). These patients were individually age, sex, and disease duration matched with UC patients without neoplasia. Primary sclerosing cholangitis and family history of CRC were recorded. Patients were genotyped for 314 of the most commonly IBD-associated SNPs by a custom SNP microarray. Logistic regression and Fischer exact test were used for statistical analysis. Results After Bonferroni correction, none of the 314 IBD-associated SNPs correlated with UC-neoplasia when compared with matched UC controls. The incidence of primary sclerosing cholangitis was greater in the UC-neoplasia group (10/41, 24% vs 3/41, 7%; P =.03) compared with UC controls. The severity of neoplasia (low grade dysplasia versus high grade dysplasia versus CRC) correlated with disease duration (7.9 vs 13.4 vs 20.7 years, respectively). Conclusion The lack of correlation between well-known IBD-associated SNPs and UC-neoplasia demonstrated in this study suggests that the development of neoplasia in patients with UC is associated with genetic determinants other than those that predispose to inflammation or results from posttranslational modifications or epigenetic factors rather than germline polymorphisms.

UR - http://www.scopus.com/inward/record.url?scp=84904260908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904260908&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2014.03.017

DO - 10.1016/j.surg.2014.03.017

M3 - Article

C2 - 24947639

AN - SCOPUS:84904260908

VL - 156

SP - 253

EP - 262

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 2

ER -